Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surgical Procedures, Operative | 10 | 2024 | 1923 | 2.220 |
Why?
|
Quality Improvement | 15 | 2024 | 3801 | 1.380 |
Why?
|
Thyroid Neoplasms | 6 | 2024 | 2331 | 1.260 |
Why?
|
Pancreatectomy | 6 | 2022 | 811 | 1.240 |
Why?
|
Pancreaticoduodenectomy | 8 | 2024 | 509 | 1.240 |
Why?
|
Risk Adjustment | 5 | 2020 | 601 | 1.220 |
Why?
|
Hospitals | 6 | 2024 | 3881 | 1.190 |
Why?
|
Neuroendocrine Tumors | 4 | 2023 | 641 | 1.130 |
Why?
|
Postoperative Complications | 17 | 2024 | 15634 | 1.080 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2024 | 163 | 0.960 |
Why?
|
Surgical Wound Infection | 8 | 2024 | 1530 | 0.920 |
Why?
|
Antibiotic Prophylaxis | 4 | 2024 | 637 | 0.840 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2022 | 43 | 0.810 |
Why?
|
Registries | 12 | 2021 | 8236 | 0.730 |
Why?
|
Hypocalcemia | 2 | 2023 | 200 | 0.730 |
Why?
|
Thyroidectomy | 4 | 2023 | 908 | 0.710 |
Why?
|
Lymph Node Excision | 2 | 2016 | 1269 | 0.700 |
Why?
|
Pancreatic Fistula | 3 | 2023 | 148 | 0.650 |
Why?
|
Group Practice | 1 | 2020 | 151 | 0.640 |
Why?
|
Cancer Care Facilities | 2 | 2018 | 422 | 0.620 |
Why?
|
Protective Devices | 1 | 2018 | 72 | 0.600 |
Why?
|
Reoperation | 6 | 2020 | 4304 | 0.590 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2165 | 0.570 |
Why?
|
Drainage | 3 | 2020 | 1158 | 0.560 |
Why?
|
Telomere | 2 | 2013 | 938 | 0.550 |
Why?
|
Liver Neoplasms | 3 | 2022 | 4308 | 0.520 |
Why?
|
Bronchitis, Chronic | 1 | 2016 | 82 | 0.500 |
Why?
|
Leukocytes | 2 | 2013 | 2024 | 0.480 |
Why?
|
Smoke | 1 | 2016 | 236 | 0.470 |
Why?
|
Cefoxitin | 3 | 2023 | 35 | 0.450 |
Why?
|
Hepatectomy | 1 | 2017 | 557 | 0.450 |
Why?
|
Pancreatic Neoplasms | 3 | 2022 | 5366 | 0.450 |
Why?
|
Emphysema | 1 | 2016 | 238 | 0.440 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 571 | 0.430 |
Why?
|
Patient Readmission | 6 | 2020 | 3268 | 0.420 |
Why?
|
Hematoma | 1 | 2018 | 763 | 0.420 |
Why?
|
Neoplasms | 5 | 2020 | 22125 | 0.390 |
Why?
|
Thyroid Nodule | 3 | 2024 | 764 | 0.380 |
Why?
|
United States | 20 | 2024 | 72337 | 0.380 |
Why?
|
Endosonography | 1 | 2015 | 608 | 0.370 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 955 | 0.360 |
Why?
|
Hospital Costs | 1 | 2017 | 947 | 0.360 |
Why?
|
Vitamin B Complex | 1 | 2013 | 299 | 0.360 |
Why?
|
Catheter Ablation | 1 | 2024 | 2751 | 0.350 |
Why?
|
Laparoscopy | 1 | 2022 | 2030 | 0.350 |
Why?
|
Point-of-Care Systems | 4 | 2023 | 1213 | 0.350 |
Why?
|
Aftercare | 1 | 2016 | 913 | 0.350 |
Why?
|
Intestinal Neoplasms | 2 | 2023 | 314 | 0.340 |
Why?
|
Quality of Life | 5 | 2024 | 13362 | 0.340 |
Why?
|
Postoperative Care | 1 | 2016 | 1469 | 0.340 |
Why?
|
Preoperative Care | 2 | 2019 | 2242 | 0.340 |
Why?
|
Colectomy | 4 | 2019 | 686 | 0.340 |
Why?
|
Carbon | 1 | 2013 | 665 | 0.330 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 790 | 0.310 |
Why?
|
Humans | 67 | 2024 | 761098 | 0.300 |
Why?
|
Propensity Score | 5 | 2019 | 1913 | 0.300 |
Why?
|
Mortality | 2 | 2018 | 2896 | 0.300 |
Why?
|
Heart Arrest | 1 | 2018 | 1514 | 0.290 |
Why?
|
Rectal Neoplasms | 1 | 2016 | 1156 | 0.290 |
Why?
|
Retrospective Studies | 22 | 2024 | 80673 | 0.290 |
Why?
|
Physician-Patient Relations | 2 | 2020 | 3238 | 0.290 |
Why?
|
Bariatric Surgery | 1 | 2017 | 991 | 0.290 |
Why?
|
Middle Aged | 32 | 2024 | 220835 | 0.290 |
Why?
|
General Surgery | 1 | 2018 | 1692 | 0.280 |
Why?
|
Surgery, Computer-Assisted | 1 | 2015 | 1004 | 0.280 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1790 | 0.270 |
Why?
|
Liver | 2 | 2023 | 7513 | 0.260 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2316 | 0.260 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3450 | 0.260 |
Why?
|
Benchmarking | 2 | 2024 | 1045 | 0.260 |
Why?
|
Occupational Exposure | 1 | 2016 | 1814 | 0.260 |
Why?
|
Liver Transplantation | 1 | 2017 | 2329 | 0.250 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6340 | 0.250 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2293 | 0.240 |
Why?
|
Aged | 26 | 2024 | 169266 | 0.230 |
Why?
|
Nutritional Status | 1 | 2013 | 1597 | 0.230 |
Why?
|
Health Expenditures | 1 | 2017 | 2363 | 0.230 |
Why?
|
Biopsy, Fine-Needle | 3 | 2024 | 1118 | 0.220 |
Why?
|
Patient Discharge | 1 | 2016 | 3441 | 0.210 |
Why?
|
Male | 31 | 2024 | 360675 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10213 | 0.200 |
Why?
|
Female | 30 | 2024 | 392458 | 0.190 |
Why?
|
Quality of Health Care | 1 | 2017 | 4319 | 0.190 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3200 | 0.190 |
Why?
|
Length of Stay | 4 | 2019 | 6420 | 0.190 |
Why?
|
Risk Assessment | 6 | 2023 | 24013 | 0.180 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3352 | 0.180 |
Why?
|
Databases, Factual | 6 | 2019 | 7969 | 0.180 |
Why?
|
Prognosis | 5 | 2023 | 29672 | 0.180 |
Why?
|
Analgesics | 2 | 2018 | 1067 | 0.180 |
Why?
|
Watchful Waiting | 1 | 2024 | 489 | 0.170 |
Why?
|
Fees, Pharmaceutical | 1 | 2020 | 66 | 0.170 |
Why?
|
Vitamin D | 1 | 2013 | 3302 | 0.160 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2022 | 323 | 0.160 |
Why?
|
Organometallic Compounds | 1 | 2022 | 647 | 0.150 |
Why?
|
Survival Rate | 5 | 2019 | 12727 | 0.150 |
Why?
|
Microfluidics | 1 | 2023 | 651 | 0.150 |
Why?
|
Melanoma | 1 | 2016 | 5694 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 629 | 0.140 |
Why?
|
Biliary Tract Neoplasms | 1 | 2019 | 185 | 0.140 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2018 | 296 | 0.140 |
Why?
|
Perioperative Period | 1 | 2018 | 252 | 0.140 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11475 | 0.140 |
Why?
|
Diverticulitis, Colonic | 1 | 2018 | 138 | 0.140 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5809 | 0.140 |
Why?
|
Cholestasis | 1 | 2019 | 378 | 0.130 |
Why?
|
Anastomotic Leak | 1 | 2017 | 163 | 0.130 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2021 | 419 | 0.130 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20120 | 0.130 |
Why?
|
Risk Factors | 7 | 2020 | 74219 | 0.130 |
Why?
|
Logistic Models | 4 | 2019 | 13254 | 0.130 |
Why?
|
Cholesterol, HDL | 1 | 2021 | 1812 | 0.120 |
Why?
|
Diet | 1 | 2013 | 8047 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2024 | 64670 | 0.120 |
Why?
|
Psychometrics | 1 | 2024 | 3061 | 0.120 |
Why?
|
Immunoassay | 3 | 2023 | 743 | 0.120 |
Why?
|
Adult | 17 | 2024 | 221083 | 0.110 |
Why?
|
Vitamin D Deficiency | 1 | 2023 | 1388 | 0.110 |
Why?
|
Perioperative Care | 2 | 2018 | 1037 | 0.110 |
Why?
|
Canada | 1 | 2018 | 2125 | 0.110 |
Why?
|
Choice Behavior | 1 | 2018 | 824 | 0.100 |
Why?
|
Anesthetics | 1 | 2018 | 523 | 0.100 |
Why?
|
Vitamin D-Binding Protein | 1 | 2013 | 130 | 0.100 |
Why?
|
Vitamin B 6 | 1 | 2013 | 234 | 0.100 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1738 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 554 | 0.090 |
Why?
|
Cohort Studies | 6 | 2024 | 41486 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2018 | 2424 | 0.090 |
Why?
|
Choline | 1 | 2013 | 515 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9278 | 0.090 |
Why?
|
Receptors, Calcitriol | 1 | 2013 | 360 | 0.090 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7405 | 0.090 |
Why?
|
Methionine | 1 | 2013 | 570 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1386 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15513 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1139 | 0.090 |
Why?
|
Equipment Design | 1 | 2018 | 3509 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3197 | 0.090 |
Why?
|
Vitamin B 12 | 1 | 2013 | 524 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6817 | 0.080 |
Why?
|
Mastectomy | 1 | 2018 | 1817 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2586 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2024 | 5249 | 0.080 |
Why?
|
Social Identification | 1 | 2009 | 108 | 0.080 |
Why?
|
Nanotubes | 1 | 2009 | 82 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2218 | 0.080 |
Why?
|
Genotype | 2 | 2013 | 12983 | 0.080 |
Why?
|
Pilot Projects | 2 | 2018 | 8639 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7386 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12467 | 0.070 |
Why?
|
Pancreatitis | 1 | 2015 | 1097 | 0.070 |
Why?
|
Mammaplasty | 1 | 2018 | 1232 | 0.070 |
Why?
|
Body Mass Index | 2 | 2017 | 12951 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2019 | 58946 | 0.070 |
Why?
|
Limbus Corneae | 1 | 2008 | 143 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2420 | 0.070 |
Why?
|
Ethanol | 1 | 2013 | 1322 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2528 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2017 | 1394 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1323 | 0.060 |
Why?
|
Calcium | 2 | 2023 | 5720 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2164 | 0.060 |
Why?
|
Culture | 1 | 2009 | 623 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2013 | 15915 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10083 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8519 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3923 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3808 | 0.060 |
Why?
|
Antibodies | 2 | 2023 | 2415 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12058 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2009 | 1201 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39121 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2018 | 2423 | 0.050 |
Why?
|
Piperacillin | 1 | 2023 | 37 | 0.050 |
Why?
|
Clinical Competence | 1 | 2019 | 4786 | 0.050 |
Why?
|
Penicillanic Acid | 1 | 2023 | 41 | 0.050 |
Why?
|
Comorbidity | 1 | 2018 | 10514 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2009 | 1767 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2019 | 1436 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7804 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2016 | 5296 | 0.050 |
Why?
|
Veterans | 1 | 2016 | 2652 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6504 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2013 | 26068 | 0.050 |
Why?
|
Parathyroidectomy | 1 | 2023 | 242 | 0.050 |
Why?
|
Health Behavior | 1 | 2013 | 2641 | 0.050 |
Why?
|
Mesentery | 1 | 2022 | 202 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 317 | 0.050 |
Why?
|
Somatostatin | 1 | 2023 | 447 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 54419 | 0.050 |
Why?
|
Meningioma | 1 | 2009 | 1216 | 0.050 |
Why?
|
Meningeal Neoplasms | 1 | 2009 | 1246 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 39953 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2021 | 299 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12975 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15845 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7189 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11701 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 1989 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4386 | 0.040 |
Why?
|
Ebolavirus | 1 | 2021 | 247 | 0.040 |
Why?
|
Recovery of Function | 2 | 2019 | 2981 | 0.040 |
Why?
|
Incidence | 1 | 2016 | 21357 | 0.040 |
Why?
|
Ileostomy | 1 | 2018 | 121 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2021 | 675 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 858 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2023 | 1803 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2020 | 616 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2024 | 1401 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6067 | 0.030 |
Why?
|
Intestine, Small | 1 | 2022 | 1207 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 1 | 2006 | 1643 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2009 | 3776 | 0.030 |
Why?
|
Biopsy | 2 | 2023 | 6781 | 0.030 |
Why?
|
Young Adult | 3 | 2019 | 59199 | 0.030 |
Why?
|
Polymers | 1 | 2022 | 1617 | 0.030 |
Why?
|
Glycoproteins | 1 | 2021 | 2203 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2638 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9416 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2054 | 0.030 |
Why?
|
Heart-Assist Devices | 1 | 2023 | 1288 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1750 | 0.030 |
Why?
|
Overweight | 1 | 2023 | 2418 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1292 | 0.020 |
Why?
|
Glioblastoma | 1 | 2006 | 3481 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1669 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8836 | 0.020 |
Why?
|
Ultrasonography | 1 | 2024 | 5971 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11856 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3330 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1116 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20981 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4565 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4014 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2757 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3149 | 0.020 |
Why?
|
Korea | 1 | 2009 | 98 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2023 | 3258 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2487 | 0.020 |
Why?
|
Endoscopy | 1 | 2019 | 1852 | 0.020 |
Why?
|
Puerto Rico | 1 | 2009 | 378 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2008 | 147 | 0.020 |
Why?
|
Acculturation | 1 | 2009 | 178 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36418 | 0.020 |
Why?
|
Polyesters | 1 | 2009 | 371 | 0.020 |
Why?
|
Stents | 1 | 2019 | 3177 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2009 | 696 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2009 | 944 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4245 | 0.020 |
Why?
|
New York City | 1 | 2009 | 730 | 0.020 |
Why?
|
Gene Expression | 2 | 2009 | 7567 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6585 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5828 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14676 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1008 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2009 | 961 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22157 | 0.020 |
Why?
|
Adenoviridae | 1 | 2009 | 1084 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2006 | 9025 | 0.020 |
Why?
|
Conjunctiva | 1 | 2008 | 479 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2009 | 749 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2008 | 11066 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10758 | 0.010 |
Why?
|
China | 1 | 2009 | 2374 | 0.010 |
Why?
|
Adolescent | 2 | 2023 | 88271 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2006 | 1607 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3803 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7400 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6312 | 0.010 |
Why?
|
Virus Replication | 1 | 2009 | 2426 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12937 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2006 | 1433 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5775 | 0.010 |
Why?
|
Genome, Human | 1 | 2009 | 4423 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5870 | 0.010 |
Why?
|
Macrophages | 1 | 2009 | 5754 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168083 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12743 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 16947 | 0.010 |
Why?
|